Highlights
First study to examine the contribution of the Big 5 personality traits, health anxiety, and COVID-19 psychological distress to generalised anxiety and depressive symptoms.
COVID-19 psychological distress predicts generalised anxiety and depressive symptoms beyond all other variables.
Specific personality traits appear to be protective of COVID-19 psychological distress.
Low self-esteem is a feature of several mental health disorders that has been directly treated with Cognitive-Behavioral Therapy (CBT). The aim of our study was to determine the efficacy of interventions for improving low self-esteem in adults by utilizing the model outlined in Fennell (1997; 1998; 1999). A literature search identified 8 studies that met the inclusion criteria of CBT-based interventions for low self-esteem using this model, 7 of which were used in a quantitative synthesis. These studies included weekly group and individual sessions and one-day workshop formats. Summary effect sizes of 1.12 and 0.34 at post-treatment were observed, with low levels of heterogeneity, for weekly sessions and one-day workshops, respectively. Comparable results were found for the reduction of depressive symptoms. Results suggest that CBT-based interventions may be efficacious for treating individuals with low self-esteem, according to changes in self-report measures; however, it is unclear whether these interventions are dissimilar to those aimed at reducing depression.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Highlights Self-critical rumination and negative metacognitions about self-critical rumination are predictive of self-esteem when controlling for affect, levels of self-criticism and general metacognitions The process of self-critical rumination, driven and maintained by metacognitions, partially mediates the relationship between depression and self-esteem
Metacognitions about smoking appear to be a stronger mediator than smoking outcome expectancies in the relationship between negative affect and cigarette use/nicotine dependence. The implications of these findings are discussed.
Background: Past research has correlated social media use with a variety of mental health outcomesboth positive and negative. The current study aims to explore two possible moderators of the link between social media use and mental health outcomes; specifically, the effects of having an anxious and/or avoidant attachment style. Method: A cross-sectional correlational design was implemented. Participants (n ¼ 124). aged 18 years completed scales measuring experiences in close relationships, general problematic Internet use, psychological wellbeing and satisfaction with life. Results: Negative relationships between problematic social media use and both psychological wellbeing and life satisfaction were observed. For psychological wellbeing, the relationship was strongest amongst individuals who were low in avoidant attachment and high in anxious attachment. Discussion: These results suggest that attachment style impacts the extent that social media affects user mental health and wellbeing; partly explaining paradoxical results in previous research.
Conclusion:We suggest that individuals who are high in anxious attachment and low in attachment avoidance may be more susceptible to negative outcomes arising from problematic SNS use.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.